TMCnet News
PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2026 financial results on Wednesday, November 4, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and may be accessed on PacBio’s website at https://investor.pacificbiosciences.com/. Date: Wednesday, November 4, 2026, at 4:30 p.m. ET (1:30 p.m. PT) About PacBio PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions t help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit?www.pacb.com?and follow @PacBio.? PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.? Contacts Investors: Media: 
|
